Gilead Sciences (GILD) Stock: What to Know Before the Market Opens on December 22, 2025
Ahead of the U.S. market open on Monday, December 22, 2025 (the next trading session after Friday’s close), Gilead Sciences, Inc. (NASDAQ: GILD) is in focus for two reasons that matter to both short-term traders and long-term investors: a new U.S. government drug-pricing agreement that could reshape near-term sentiment across big pharma, and fresh late-stage HIV pipeline success that reinforces Gilead’s core franchise heading into 2026. Gilead+1 Below is a market-ready briefing—current catalysts, what analysts are watching, key numbers, and the biggest risks—written for readers looking to understand what could move GILD stock as the bell approaches. GILD stock snapshot